Welcome to our dedicated page for Cellebrite DI Ltd. news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite DI Ltd. stock.
Cellebrite DI Ltd. (Nasdaq: CLBT) is an Israeli digital intelligence company renowned for delivering comprehensive tools and solutions to federal, state, and local law enforcement, as well as enterprise companies and service providers. The company’s offerings assist in the collection, review, analysis, and management of digital data.
Core Business: Cellebrite's suite of products includes the UFED series for data extraction from mobile devices, Physical Analyzer for deep digital data analysis, UFED Cloud for cloud data retrieval, Frontliner, Responder, Premium, and Seeker, each designed to serve different aspects of digital investigations.
Recent Achievements and Projects: Recently, Cellebrite has partnered with Coalfire to enable U.S. federal customers to access Cellebrite's SaaS technology. This collaboration is part of Cellebrite's ongoing efforts to achieve FedRAMP authorization, ensuring the highest standards of security and data compliance for its SaaS solutions.
Financial Condition: For the first quarter of 2024, the company reported strong financial performance with expanded business globally and improved profitability. Cellebrite has reaffirmed its optimistic outlook for the remainder of the year, expecting to drive substantial revenue and adjusted EBITDA growth.
Partnerships: Collaborating with cybersecurity leader Coalfire, Cellebrite aims to strengthen its FedRAMP authorization process, reflecting a commitment to robust security standards.
Products and Solutions: Cellebrite’s SaaS-based solutions, like Guardian and Endpoint Inspector SaaS, offer scalable, secure data management and evidence sharing, enhancing operational efficiency and collaboration between investigators. These solutions ensure consent-based data collection, adhering to ethical and legal standards.
Significance: Cellebrite’s mission is to protect and save lives, accelerate justice, and preserve privacy. Their digital investigative solutions empower organizations to master the complexities of legally sanctioned investigations, transforming data collection and analysis processes. Trusted globally, their platform is instrumental in advancing digital investigations for both public and private sectors.
D-Fend Solutions has secured $31M in a new investment round led by Israel Growth Partners (IGP), with participation from Vertex Ventures and Vertex Growth. The company, specializing in RF cyber-based counter-drone technology, reported over 60% year-over-year revenue growth and expansion across nearly 30 countries, including Five Eyes alliance, G7, and NATO member states.
The funding will support technological advancement, market expansion, and addressing evolving drone threats. D-Fend's flagship product, EnforceAir, uses RF cyber-takeover techniques to neutralize rogue drones safely without operational disruption. The technology has been recognized by Booz Allen Hamilton and is deployed to protect military zones, airports, critical infrastructure, prisons, and public events.
Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, announced its participation in the upcoming UBS Global Technology and AI Conference. The company will participate in a fireside chat on December 3, 2024, at 4:55 p.m. ET. Key executives attending include Thomas Hogan (executive chairman), Dana Gerner (CFO), and Andrew Kramer (VP of investor relations).
Cellebrite (Nasdaq: CLBT) and Relativity announced the general availability of Cellebrite's mobile collection solutions integration into RelativityOne platform. The integration enables faster and more efficient mobile data management in legal processes. Following a successful Advanced Access program in July 2024, users reported significant efficiency gains, reducing mobile device data collection time to just over an hour compared to previous days or weeks. The integration allows remote mobile device collections to be fully orchestrated within RelativityOne, including custodian notification and automatic data transfer. According to Cellebrite's 2024 Industry Trends survey, 97% of eDiscovery cases now involve at least one mobile device.
Cellebrite reported strong Q3 2024 financial results, achieving a significant milestone with quarterly revenue exceeding $100 million for the first time. Revenue reached $106.9 million, up 27% year-over-year, driven by 27% growth in subscription revenue to $93.4 million. The company's Annual Recurring Revenue (ARR) grew 26% to $370.8 million, with a net retention rate of 124%.
Key highlights include adjusted EBITDA of $31.3 million with a 29.3% margin. The company announced Pathfinder in the Cloud with AWS and received a patent for Remote Mobile Collection. Based on strong performance, Cellebrite increased its 2024 outlook for revenue to $397-401 million and adjusted EBITDA to $94-100 million, while raising the low end of its ARR target range to $390-400 million.
Cellebrite (NASDAQ: CLBT) announced that CEO Yossi Carmil will step down from his position and Board of Directors by December 31, 2024. Executive Chairman Thomas E. Hogan will serve as interim CEO while the company conducts a formal search for a new chief executive. Under Carmil's 19-year leadership, Cellebrite grew from 18 to over 1,100 employees, expanded to dozen offices worldwide, and serves approximately 7,000 customers in more than 100 countries. Notable achievements include taking the company public in 2021, transitioning to a subscription business model, and launching the AI-driven Case-to-Closure platform. The company's market valuation has doubled to approximately $4 billion since going public.
Cellebrite (NASDAQ: CLBT) reported strong Q3 2024 results, achieving a milestone of $106.9 million in quarterly revenue, up 27% year-over-year. Subscription revenue grew 27% to $93.4 million, while Annual Recurring Revenue (ARR) reached $370.8 million, up 26% year-over-year. The company reported an Adjusted EBITDA of $31.3 million with a 29.3% margin. Despite posting a GAAP net loss of $207.1 million, non-GAAP net income was $31.8 million. Based on strong performance, Cellebrite increased its 2024 outlook for revenue and adjusted EBITDA, raising the low end of the ARR target range to $390-400 million.
Cellebrite (NASDAQ: CLBT) announced Tim Tebow as the keynote speaker for their inaugural Case-to-Closure (C2C) User Summit scheduled for March 31-April 3, 2025, in Washington, D.C. The summit will gather digital investigation leaders to discuss industry trends and best practices. Tebow will address his foundation's global fight against human trafficking, aligning with Cellebrite's Operation Find Them All initiative. The event will feature over three dozen speakers covering various digital investigative topics, including notable case studies and technological developments. Attendees will have opportunities for networking, professional training, and knowledge expansion across different levels of the investigative process.
Cellebrite (Nasdaq: CLBT), a leader in Digital Investigative solutions, has patented its Remote Mobile Collection technology. This innovation, available in Cellebrite's SaaS platforms Endpoint Mobile Now and Endpoint Inspector, enables corporate investigators to perform immediate, targeted remote data collection from mobile devices.
Key benefits include:
- Time and cost savings for businesses
- Faster device access and analysis
- Convenience for device owners, who can retain their devices during collection
- Ability to collect data from multiple devices simultaneously
- Improved data accessibility with results available within hours
According to Cellebrite's 2024 Industry Trends Survey, 83% of respondents rely on multiple tools for data collection. This patented technology aims to streamline this process, particularly in today's hybrid work environment.
Cellebrite DI (Nasdaq: CLBT) has announced the results of its completed redemption of all outstanding warrants. Key points include:
- 99.4% of outstanding Public Warrants were exercised, with 4,645 exercised for cash and 19,878,580 exercised cashlessly.
- 116,224 unexercised Public Warrants were redeemed for $11,622.40.
- All 9,666,667 Private Placement Warrants were exercised cashlessly.
- Public Warrants have stopped trading on Nasdaq and been delisted.
- The redemption does not affect the trading of Cellebrite's Ordinary Shares (CLBT).
Cellebrite (Nasdaq: CLBT) has announced the availability of Pathfinder in the Cloud with Amazon Web Services (AWS), enhancing its investigative analytics solution for law enforcement agencies. This cloud-based offering allows customers to access Pathfinder through Amazon's secure Virtual Private Cloud (VPC), providing flexible deployment options and scalable resources.
Key features of Pathfinder include AI-driven data analysis, slang identification, explicit image categorization, Optical Character Recognition (OCR), and Automated Translation Services. The cloud deployment eliminates the need for physical servers and secure rooms, offering cost-effective scaling, rapid resource commissioning, and high availability.
This update aims to accelerate digital evidence analysis, reduce investigation time, and improve case resolution efficiency for law enforcement agencies of all sizes.
FAQ
What is the current stock price of Cellebrite DI Ltd. (CLBT)?
What is the market cap of Cellebrite DI Ltd. (CLBT)?
What does Cellebrite DI Ltd. specialize in?
What are some of the key products offered by Cellebrite?
What recent collaboration has Cellebrite engaged in?
What are Cellebrite's financial expectations for 2024?
How does Cellebrite ensure the security of its solutions?
What is Cellebrite's mission?
Who are the typical users of Cellebrite’s products?
What makes Cellebrite’s SaaS solutions unique?
Where can investors find detailed financial information about Cellebrite?
How does Cellebrite contribute to digital investigations?
